Literature DB >> 10773392

Premature ovarian failure.

W Vegetti1, A Marozzi, E Manfredini, G Testa, F Alagna, A Nicolosi, I Caliari, M Taborelli, M G Tibiletti, L Dalprà, P G Crosignani.   

Abstract

Secondary amenorrhoea with elevated gonadotrophins occurring under the age of 40 (premature ovarian failure (POF)), and at the age between 41 and 44 years (early menopause (EM)), respectively, affects 1-2% and 5% of women in the general population. Objective of this study was to evaluate the prevalence of familial cases of POF and EM and to assess the clinical and genetic characteristics of these patients. One hundred and sixty women with idiopathic secondary amenorrhoea before the age of 45 and serum follicle-stimulating hormone (FSH) levels greater than or equal to 40 IU/l were included in the study. Tests performed on patients included complete medical history, pedigree's analysis, clinical pelvic examination, gonadotrophins and thyroid assessment, chromosomal analysis. The 160 patients included in the study showed idiopathic POF (n=130) or EM (n=30). Following pedigree assessment, we were able to identify an incidence of familial cases of 28.5% in the POF group (n=37) and of 50% in the EM group (n=15). POF and EM condition were often present in the same family. There were no differences between POF and EM patients and between familial and sporadic cases regarding age at menarche, personal history, gynaecological history, weight, height and diet habits. There was a statistically significant difference between sporadic and familial cases in age at POF onset: 32.0+/-7.3 years (12-40) compared to 35. 0+/-5.8 (18-40), respectively (P<0.05). The POF and EM families identified showed two or more affected females and transmission through either maternal or paternal relatives; in four families both maternal and paternal transmission was observed. This study suggests that idiopathic POF and EM conditions, differing only in age of menopause onset, may represent a variable expression of the same genetic disease. The different age of menopause onset in these patients may be explained by genetic heterogeneity and/or by different environmental factors. Our results indicate a high rate of familial transmission of the condition. Pedigree's analysis suggests an autosomal or an X-linked dominant sex-limited pattern of inheritance for POF and EM.

Entities:  

Mesh:

Year:  2000        PMID: 10773392     DOI: 10.1016/s0303-7207(99)00224-5

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

1.  Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age.

Authors:  Kristel M van Asselt; Helen S Kok; Hein Putter; Cisca Wijmenga; Petra H M Peeters; Yvonne T van der Schouw; Diederick E Grobbee; Egbert R te Velde; Sietse Mosselman; Peter L Pearson
Journal:  Am J Hum Genet       Date:  2004-02-04       Impact factor: 11.025

2.  Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure.

Authors:  Arnaud Lacombe; Hane Lee; Laila Zahed; Mahmoud Choucair; Jean-Marc Muller; Stanley F Nelson; Wael Salameh; Eric Vilain
Journal:  Am J Hum Genet       Date:  2006-05-26       Impact factor: 11.025

3.  Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF).

Authors:  C R Quilter; A C Karcanias; M R Bagga; S Duncan; A Murray; G S Conway; C A Sargent; N A Affara
Journal:  Hum Reprod       Date:  2010-06-22       Impact factor: 6.918

4.  Mother's menopausal age is associated with her daughter's early follicular phase urinary follicle-stimulating hormone level.

Authors:  Anne Z Steiner; Donna D Baird; James S Kesner
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

5.  Blood cell mitochondrial DNA content and premature ovarian aging.

Authors:  Marco Bonomi; Edgardo Somigliana; Chiara Cacciatore; Marta Busnelli; Raffaella Rossetti; Silvia Bonetti; Alessio Paffoni; Daniela Mari; Guido Ragni; Luca Persani
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

6.  Genome-wide linkage in a highly consanguineous pedigree reveals two novel loci on chromosome 7 for non-syndromic familial Premature Ovarian Failure.

Authors:  Sandrine Caburet; Petra Zavadakova; Ziva Ben-Neriah; Kamal Bouhali; Aurélie Dipietromaria; Céline Charon; Céline Besse; Paul Laissue; Vered Chalifa-Caspi; Sophie Christin-Maitre; Daniel Vaiman; Giovanni Levi; Reiner A Veitia; Marc Fellous
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

7.  Age at Menopause and Its Main Predictors among Iranian Women.

Authors:  Fatemeh Shobeiri; Mansour Nazari
Journal:  Int J Fertil Steril       Date:  2014-11-01

8.  Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human.

Authors:  M Mashayekhi; E Mirzadeh; Z Chekini; F Ahmadi; P Eftekhari-Yazdi; S Vesali; T Madani; N Aghdami
Journal:  J Ovarian Res       Date:  2021-01-06       Impact factor: 4.234

9.  Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case report.

Authors:  Maria Giuseppina Miano; Carmela Laperuta; Pietro Chiurazzi; Michele D'Urso; Matilde Valeria Ursini
Journal:  BMC Med Genet       Date:  2007-04-11       Impact factor: 2.103

10.  Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.

Authors:  Martine Berliere; Florence Dalenc; Nathalie Malingret; Anita Vindevogel; Philippe Piette; Henry Roche; Jacques Donnez; Michel Symann; Joseph Kerger; Jean-Pascal Machiels
Journal:  BMC Cancer       Date:  2008-02-21       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.